We also found that the overexpression of DDIT4 was significantly correlated with different tumor stages, patient age, primary subtypes, major subclasses with TNBC, nodal metastasis status, and TP53 mutation status (Fig. 6), indicating a strong correlation between DDIT4 overexpression and breast cancer progression. This evidence concerns the gene TP53 and breast cancer.